Your fact-checks will appear here
Neuralink's human trials for BCIs, including initial results and patient procedures as of 2024-2025.
Neuralink began first-in-human, early-feasibility trials in 2024 after FDA clearance and publicly announced its first implant in late January 2024, reporting users can move cursors, play games and ope...
There is no credible reporting in the supplied sources that Elon Musk "left the US over Alzheimer drugs"; available coverage instead shows Musk commenting on Alzheimer's research, pursuing Neuralink t...
The “memory product” most directly promoted by Elon Musk is Neuralink’s brain‑computer interface — a surgically implanted device the company says could one day augment or restore memory by connecting ...
There is no reporting in the provided sources that Elon Musk or any of his companies have funded medical research specifically into bladder disorders; the documents focus on Musk’s role in federal NIH...
Neuralink has begun first-in-human implants and publicly shared demonstrations and company updates describing people with paralysis using the device to move cursors, play games and operate smartphones...
There is no credible reporting in the provided sources that Elon Musk has endorsed, created, or sells "neuropathy pills"; instead the material documents a pattern of social-media scams and misattribut...
Elon Musk has promoted brain‑computer interfaces (BCIs) via Neuralink as capable of treating neurological diseases and has suggested they could help with dementia, but current reporting shows only ear...